Incidence of erosions / ulcers in patients with OA

0

25

50

75

Gastric

Patients with Erosions/Ulcers (%)

Duodenal

*

*

* Significantly different from all other treatments; P < 0.001

Placebo (n=247)

Celecoxib 50 mg 2x/d (n=258)

Celecoxib 100 mg 2x/d (n=239)

Celecoxib 200 mg 2x/d (n=237)

Naproxen 500 mg 2x/d (n=233)

Data on file : Searle Study 021

Previous slide

Next slide

Back to first slide

View graphic version